Difference between revisions of "Psoriasis"
m (Protected "Psoriasis" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
==Acceptability at CT / Work-Up== | ==Acceptability at CT / Work-Up== | ||
| − | + | Severe cases NOT ACCEPTABLE | |
| + | |||
| + | Mild or moderate cases acceptable for BMH. May be acceptable for PBSC and this should be reviewed on a case-by-case basis. | ||
==Individual at Risk== | ==Individual at Risk== | ||
| Line 14: | Line 16: | ||
==Guidance== | ==Guidance== | ||
| − | Unacceptable if severe or widespread, or has ever suffered from psoriatic | + | Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression. |
| + | |||
| + | Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation. | ||
| − | + | Retinoic acid derivatives such as acitretin are acceptable, as long as the appropriate time period has passed since their administration and donation. See [[Retinoic Acid Derivatives]]. | |
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
| Line 22: | Line 26: | ||
==Version== | ==Version== | ||
| − | Version 1, Edition | + | Version 1, Edition 3 |
====Date of Last Update==== | ====Date of Last Update==== | ||
| − | + | 7 September 2016 | |
Latest revision as of 16:00, 7 September 2016
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
Severe cases NOT ACCEPTABLE
Mild or moderate cases acceptable for BMH. May be acceptable for PBSC and this should be reviewed on a case-by-case basis.
Individual at Risk
Recipient
Explanation of Condition
Autoimmune condition causing scaling and redness of the skin, in characteristic patches.
See also Psoriasis
Guidance
Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.
Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation.
Retinoic acid derivatives such as acitretin are acceptable, as long as the appropriate time period has passed since their administration and donation. See Retinoic Acid Derivatives.
Pseudonyms or Related Conditions
Version
Version 1, Edition 3
Date of Last Update
7 September 2016
